Xeris Biopharma Holdings Inc

XERS Stock Forecast & Price Prediction

A data-driven outlook for XERS built from live market pricing, discounted cash flow fair value, valuation multiples and ZCoreAI's Z-Score mean-reversion model. No opinions — only what the numbers currently imply.

$8.55+4.27% todayUSD · live quote

XERS Price Outlook

$1.12
Model fair value per share (two-stage DCF, 10-year horizon)
Implied downside of 86.9% versus the current XERS price of $8.55.
PV of projected FCF
$51.21M
PV of terminal value
$138.59M
Equity value
$189.80M
Growth assumption
25%

XERS Historical Price Context

Two years of weekly closes for XERS, with 52-week extremes and realized performance.

52-week high
$10.08
52-week low
$5.25
1-year performance
+4.0%
2-year performance
+197.0%

XERS is trading 68% of the way up its 52-week range.

XERS Valuation & Fundamentals

The multiples and growth rates that drive the XERS forecast model.

Market cap
$1.45B
P/E (TTM)
Forward P/E
37.05
EPS (TTM)
$-0.11
Revenue growth
+28.7%
EPS growth
Net margin
-5.1%
Discount rate
9%
See the full XERS DCF fair value breakdown →

XERS Technical & Smart Money Context

Live Z-Score readings measure how far XERS has stretched from its statistical regression mean on each timeframe. Extreme readings historically precede mean reversion.

1H
0.48
Statistically neutral
4H
0.32
Statistically neutral
1D
1.11
Statistically neutral

How the XERS Forecast Is Built

The XERS price prediction combines three independent layers. First, a two-stage discounted cash flow model projects free cash flow ten years forward at 25% growth, applies a 2.5% perpetual terminal growth rate, and discounts every cash flow back to today at 9%. Second, current valuation multiples are compared against the growth and margin profile the company is actually delivering. Third, a Z-Score regression model measures how far price has stretched from its statistical mean on the 1H, 4H and daily timeframes.

Fair value is a valuation anchor, not a timing tool. A stock can stay above or below model fair value for long stretches, which is why the Z-Score layer exists — it identifies when XERS is statistically stretched enough that mean reversion becomes probable. Nothing on this page is investment advice.

XERS Stock Forecast FAQ

What is the XERS stock forecast?

ZCoreAI derives the XERS forecast from a DCF fair value of $1.12, current valuation multiples, and live Z-Score mean-reversion statistics. It is a model output based on today's data, not a guarantee of future prices.

How is the XERS price prediction calculated?

Free cash flow is projected ten years forward, a Gordon-growth terminal value is capitalized, and both are discounted to present value. Net cash and debt are added to reach equity value, which is divided by shares outstanding to get a per-share number that is compared to the live XERS price.

Is XERS overvalued or undervalued right now?

On current inputs the model puts XERS above fair value by 86.9%. Model inputs change as fundamentals update.

What does the XERS Z-Score mean?

The Z-Score measures standard deviations from a regression mean. Below -3 signals an unusually stretched downside move, above +3 signals a stretched upside move, and readings in between are statistically neutral.

Can I trade XERS signals live?

Yes. Open XERS in the ZCoreAI terminal to see Smart Money structure, signal markers and fair-value overlays on the live chart, or review every recent alert on the signals page.

XERS fair value

Full DCF intrinsic value breakdown for XERS.

XERS dividends

Payout history, yield and dividend growth for XERS.

Live trading signals

Every recent Z-Score buy and sell alert across the market.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.